BiotechTube
Home/Pulmatrix/Margaret Wasilewski
MW

Margaret Wasilewski

Chief Medical Officer

Pulmatrix

Therapeutic Areas

RespiratoryNeurological

Pulmatrix Pipeline

DrugIndicationPhase
PUR3100Acute MigrainePhase 2
PUR1800Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)Phase 1b/2a
PUR1900Allergic Bronchopulmonary Aspergillosis (ABPA) in Asthma / Cystic FibrosisPhase 2
PUR0200Chronic Obstructive Pulmonary Disease (COPD)Preclinical

Leadership Team at Pulmatrix

TR
Ted Raad
Chief Executive Officer
JP
John P. Hamill
Chief Financial Officer
RW
Robert W. Clarke
Chief Operating Officer/Head of R&D
View full Pulmatrix profile